scholarly article | Q13442814 |
review article | Q7318358 |
P2093 | author name string | Maureen J O'Sullivan | |
Antonio Lázaro | |||
Lorna C Kelly | |||
P2860 | cites work | Computational identification of Drosophila microRNA genes | Q21092888 |
Post-transcriptional dysregulation by miRNAs is implicated in the pathogenesis of gastrointestinal stromal tumor [GIST] | Q21133528 | ||
An integrated analysis of miRNA and gene copy numbers in xenografts of Ewing's sarcoma | Q21198840 | ||
Mutations in RECQL4 cause a subset of cases of Rothmund-Thomson syndrome | Q22009558 | ||
The Sequence of the Human Genome | Q22065842 | ||
Central Dogma of Molecular Biology | Q22122430 | ||
The nuclear RNase III Drosha initiates microRNA processing | Q24295234 | ||
Exportin-5 mediates the nuclear export of pre-microRNAs and short hairpin RNAs | Q24302072 | ||
TRBP recruits the Dicer complex to Ago2 for microRNA processing and gene silencing | Q24306121 | ||
The Drosha-DGCR8 complex in primary microRNA processing | Q24318603 | ||
MicroRNA-145 regulates OCT4, SOX2, and KLF4 and represses pluripotency in human embryonic stem cells | Q24320635 | ||
Reversible disruption of mSWI/SNF (BAF) complexes by the SS18-SSX oncogenic fusion in synovial sarcoma | Q24337483 | ||
MicroRNA maturation: stepwise processing and subcellular localization | Q24534359 | ||
Human microRNAs are processed from capped, polyadenylated transcripts that can also function as mRNAs | Q24537328 | ||
New microRNAs from mouse and human | Q24540176 | ||
Exportin 5 is a RanGTP-dependent dsRNA-binding protein that mediates nuclear export of pre-miRNAs | Q24540256 | ||
MicroRNA genes are transcribed by RNA polymerase II | Q24562649 | ||
Distinct roles for Argonaute proteins in small RNA-directed RNA cleavage pathways | Q24564402 | ||
The product of the H19 gene may function as an RNA | Q24599284 | ||
Prognostic value of microRNA-223/epithelial cell transforming sequence 2 signaling in patients with osteosarcoma. | Q53054320 | ||
Dual role for argonautes in microRNA processing and posttranscriptional regulation of microRNA expression. | Q53510675 | ||
Upregulated expression of microRNA-214 is linked to tumor progression and adverse prognosis in pediatric osteosarcoma. | Q54243283 | ||
Extending the phenotypes associated with DICER1 mutations. | Q54564111 | ||
Survival after recurrence of Ewing tumors: the St Jude Children's Research Hospital experience, 1979-1999 | Q77783931 | ||
Overexpression of miR-22 reverses paclitaxel-induced chemoresistance through activation of PTEN signaling in p53-mutated colon cancer cells | Q84145725 | ||
miR-125b suppresses the proliferation and migration of osteosarcoma cells through down-regulation of STAT3. | Q39441445 | ||
miR-34a predicts survival of Ewing's sarcoma patients and directly influences cell chemo-sensitivity and malignancy | Q39465507 | ||
MicroRNA-199a-3p is downregulated in human osteosarcoma and regulates cell proliferation and migration | Q39526077 | ||
Identification of altered MicroRNA expression patterns in synovial sarcoma | Q39611039 | ||
Circulating muscle-specific microRNA, miR-206, as a potential diagnostic marker for rhabdomyosarcoma | Q39669508 | ||
EWS-FLI-1 modulates miRNA145 and SOX2 expression to initiate mesenchymal stem cell reprogramming toward Ewing sarcoma cancer stem cells | Q39716224 | ||
Functional elucidation of MiR-34 in osteosarcoma cells and primary tumor samples | Q39820788 | ||
NF-kappaB regulation of YY1 inhibits skeletal myogenesis through transcriptional silencing of myofibrillar genes. | Q40145024 | ||
miR-125b develops chemoresistance in Ewing sarcoma/primitive neuroectodermal tumor | Q41051759 | ||
Mechanism of chemoresistance mediated by miR-140 in human osteosarcoma and colon cancer cells | Q42009448 | ||
Analysis of miRNA-gene expression-genomic profiles reveals complex mechanisms of microRNA deregulation in osteosarcoma | Q44364850 | ||
Prognostic evaluation of microRNA-210 expression in pediatric osteosarcoma | Q45056241 | ||
MicroRNA expression signature of human sarcomas | Q47836377 | ||
Osteosarcoma and retinoblastoma: a shared chromosomal mechanism revealing recessive predisposition | Q37542430 | ||
Let-7a functions as a tumor suppressor in Ewing's sarcoma cell lines partly by targeting cyclin-dependent kinase 6. | Q37617616 | ||
miR-33a is up-regulated in chemoresistant osteosarcoma and promotes osteosarcoma cell resistance to cisplatin by down-regulating TWIST. | Q37681865 | ||
The Ewing's sarcoma oncoprotein EWS/FLI induces a p53-dependent growth arrest in primary human fibroblasts | Q38287718 | ||
Histone deacetylase inhibitors reverse SS18-SSX-mediated polycomb silencing of the tumor suppressor early growth response 1 in synovial sarcoma | Q38290415 | ||
Differential microRNA expression profiles between malignant rhabdoid tumor and epithelioid sarcoma: miR193a-5p is suggested to downregulate SMARCB1 mRNA expression | Q38310806 | ||
MiR-30a-5p connects EWS-FLI1 and CD99, two major therapeutic targets in Ewing tumor | Q38321646 | ||
A novel oncogenic mechanism in Ewing sarcoma involving IGF pathway targeting by EWS/Fli1-regulated microRNAs | Q38334606 | ||
Hsa-mir-145 is the top EWS-FLI1-repressed microRNA involved in a positive feedback loop in Ewing's sarcoma | Q38338166 | ||
MicroRNA miR-183 functions as an oncogene by targeting the transcription factor EGR1 and promoting tumor cell migration | Q38338974 | ||
RNA-RNA interactions in gene regulation: the coding and noncoding players | Q38394295 | ||
S-MED: sarcoma microRNA expression database | Q38431264 | ||
Frequent overexpression of HMGA2 in human atypical teratoid/rhabdoid tumor and its correlation with let-7a3/let-7b miRNA. | Q39034525 | ||
The histone demethylase KDM3A is a microRNA-22-regulated tumor promoter in Ewing Sarcoma | Q39041044 | ||
Study of the gene expression and microRNA expression profiles of malignant rhabdoid tumors originated in the brain (AT/RT) and in the kidney (RTK). | Q39100963 | ||
Failure to downregulate the BAF53a subunit of the SWI/SNF chromatin remodeling complex contributes to the differentiation block in rhabdomyosarcoma. | Q39144774 | ||
TGF-β1 suppression of microRNA-450b-5p expression: a novel mechanism for blocking myogenic differentiation of rhabdomyosarcoma | Q39153280 | ||
miRNA expression profile in human osteosarcoma: role of miR-1 and miR-133b in proliferation and cell cycle control. | Q39228419 | ||
MicroRNA profiling of primary high-grade soft tissue sarcomas | Q39312145 | ||
Downregulation of microRNAs miR-1, -206 and -29 stabilizes PAX3 and CCND2 expression in rhabdomyosarcoma | Q39397196 | ||
The Ewing's sarcoma EWS/FLI-1 fusion gene encodes a more potent transcriptional activator and is a more powerful transforming gene than FLI-1 | Q24629399 | ||
Distinct roles for miR-1 and miR-133a in the proliferation and differentiation of rhabdomyosarcoma cells | Q24632284 | ||
Molecular profiling uncovers a p53-associated role for microRNA-31 in inhibiting the proliferation of serous ovarian carcinomas and other cancers | Q24634248 | ||
MicroRNA-1/206 targets c-Met and inhibits rhabdomyosarcoma development | Q24648202 | ||
The role of microRNA-1 and microRNA-133 in skeletal muscle proliferation and differentiation | Q24650204 | ||
Disrupting the pairing between let-7 and Hmga2 enhances oncogenic transformation | Q24658400 | ||
Fusions of the SYT and SSX genes in synovial sarcoma | Q27824775 | ||
Mammalian microRNAs predominantly act to decrease target mRNA levels | Q27860535 | ||
Posttranscriptional regulation of the heterochronic gene lin-14 by lin-4 mediates temporal pattern formation in C. elegans | Q27860584 | ||
An extensive class of small RNAs in Caenorhabditis elegans | Q27860626 | ||
Nuclear export of microRNA precursors | Q27860686 | ||
Cancer statistics, 2013 | Q27860762 | ||
Asymmetry in the assembly of the RNAi enzyme complex | Q27860763 | ||
The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14 | Q27860849 | ||
An abundant class of tiny RNAs with probable regulatory roles in Caenorhabditis elegans | Q27860895 | ||
Identification of novel genes coding for small expressed RNAs | Q27860917 | ||
Processing of primary microRNAs by the Microprocessor complex | Q27860986 | ||
Functional siRNAs and miRNAs Exhibit Strand Bias | Q27861038 | ||
MicroRNAs: genomics, biogenesis, mechanism, and function | Q27861070 | ||
Conservation of the sequence and temporal expression of let-7 heterochronic regulatory RNA | Q27861092 | ||
The 21-nucleotide let-7 RNA regulates developmental timing in Caenorhabditis elegans | Q27861103 | ||
The Landscape of long noncoding RNA classification | Q28086829 | ||
Switching from repression to activation: microRNAs can up-regulate translation | Q28131790 | ||
The widespread regulation of microRNA biogenesis, function and decay | Q28131796 | ||
Dicer functions in RNA interference and in synthesis of small RNA involved in developmental timing in C. elegans | Q28131807 | ||
Analysis of the mouse transcriptome based on functional annotation of 60,770 full-length cDNAs | Q28131821 | ||
A novel type of RNase III family proteins in eukaryotes | Q28138347 | ||
On protein synthesis | Q28183644 | ||
The small RNA profile during Drosophila melanogaster development | Q28201894 | ||
The role of INI1 and the SWI/SNF complex in the development of rhabdoid tumors: meeting summary from the workshop on childhood atypical teratoid/rhabdoid tumors | Q28215062 | ||
Expression profiling of EWS/FLI identifies NKX2.2 as a critical target gene in Ewing's sarcoma | Q28239992 | ||
Specific activation of microRNA-127 with downregulation of the proto-oncogene BCL6 by chromatin-modifying drugs in human cancer cells | Q28245307 | ||
Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival | Q28264400 | ||
Oncogenic partnerships: EWS-FLI1 protein interactions initiate key pathways of Ewing's sarcoma | Q36930039 | ||
DICER1 mutations in embryonal rhabdomyosarcomas from children with and without familial PPB-tumor predisposition syndrome. | Q37003048 | ||
Embryonal rhabdomyosarcoma of the uterine cervix: a report of 14 cases and a discussion of its unusual clinicopathological associations. | Q37272571 | ||
The muscle-specific microRNA miR-206 blocks human rhabdomyosarcoma growth in xenotransplanted mice by promoting myogenic differentiation | Q37286651 | ||
NF-kappaB-YY1-miR-29 regulatory circuitry in skeletal myogenesis and rhabdomyosarcoma | Q37311506 | ||
Mir-214-dependent regulation of the polycomb protein Ezh2 in skeletal muscle and embryonic stem cells | Q37385808 | ||
miR-203, a tumor suppressor frequently down-regulated by promoter hypermethylation in rhabdomyosarcoma. | Q37428692 | ||
Truncating mutations of hSNF5/INI1 in aggressive paediatric cancer | Q28277002 | ||
Human RISC couples microRNA biogenesis and posttranscriptional gene silencing | Q28280424 | ||
Germ-line and acquired mutations of INI1 in atypical teratoid and rhabdoid tumors | Q28294240 | ||
Deregulated expression of miR-26a and Ezh2 in rhabdomyosarcoma | Q28304953 | ||
The mirtron pathway generates microRNA-class regulatory RNAs in Drosophila | Q29615827 | ||
The product of the mouse Xist gene is a 15 kb inactive X-specific transcript containing no conserved ORF and located in the nucleus | Q29617834 | ||
A role for the RNase III enzyme DCR-1 in RNA interference and germ line development in Caenorhabditis elegans | Q29618304 | ||
Distinct mechanisms for microRNA strand selection by Drosophila Argonautes | Q30886909 | ||
Comparing the MicroRNA spectrum between serum and plasma | Q31080442 | ||
Osteosarcoma incidence and survival rates from 1973 to 2004: data from the Surveillance, Epidemiology, and End Results Program | Q33406382 | ||
Sorting of Drosophila small silencing RNAs partitions microRNA* strands into the RNA interference pathway | Q33572957 | ||
MiR-214 and N-ras regulatory loop suppresses rhabdomyosarcoma cell growth and xenograft tumorigenesis | Q33688560 | ||
p53-Responsive micrornas 192 and 215 are capable of inducing cell cycle arrest | Q33719450 | ||
Development of Ewing's sarcoma from primary bone marrow-derived mesenchymal progenitor cells | Q33992270 | ||
Let-7a is a direct EWS-FLI-1 target implicated in Ewing's sarcoma development | Q33997274 | ||
Mesenchymal stem cell features of Ewing tumors | Q34003979 | ||
Upregulation of mir-221 and mir-222 in atypical teratoid/rhabdoid tumors: potential therapeutic targets | Q34088236 | ||
An inhibitory effect of miR-22 on cell migration and invasion in ovarian cancer | Q34140013 | ||
microRNA-143, down-regulated in osteosarcoma, promotes apoptosis and suppresses tumorigenicity by targeting Bcl-2 | Q34140671 | ||
Micro-RNA profiles in osteosarcoma as a predictive tool for ifosfamide response | Q34143825 | ||
A cancer family syndrome in twenty-four kindreds | Q34177945 | ||
Perturbation of 14q32 miRNAs-cMYC gene network in osteosarcoma | Q34228576 | ||
EWS/FLI1 regulates EYA3 in Ewing sarcoma via modulation of miRNA-708, resulting in increased cell survival and chemoresistance. | Q34283431 | ||
Genomic and clinical analysis of amplification of the 13q31 chromosomal region in alveolar rhabdomyosarcoma: a report from the Children's Oncology Group | Q34694293 | ||
Growth-promoting role of the miR-106a~363 cluster in Ewing sarcoma | Q34702270 | ||
Complementary genomic approaches highlight the PI3K/mTOR pathway as a common vulnerability in osteosarcoma | Q34793401 | ||
Localization- and mutation-dependent microRNA (miRNA) expression signatures in gastrointestinal stromal tumours (GISTs), with a cluster of co-expressed miRNAs located at 14q32.31. | Q35004231 | ||
MiR-133b is down-regulated in human osteosarcoma and inhibits osteosarcoma cells proliferation, migration and invasion, and promotes apoptosis | Q35082529 | ||
Treatment of Ewing sarcoma family of tumors: current status and outlook for the future | Q35090650 | ||
SS18-SSX-regulated miR-17 promotes tumor growth of synovial sarcoma by inhibiting p21WAF1/CIP1. | Q35200425 | ||
miRNA signatures associate with pathogenesis and progression of osteosarcoma | Q35894610 | ||
MicroRNA Involvement in Osteosarcoma | Q35898407 | ||
Emerging functional and mechanistic paradigms of mammalian long non-coding RNAs | Q36144721 | ||
Recent advances in the molecular pathogenesis of Ewing's sarcoma | Q36562720 | ||
EWS/FLI-1 silencing and gene profiling of Ewing cells reveal downstream oncogenic pathways and a crucial role for repression of insulin-like growth factor binding protein 3. | Q36701142 | ||
P275 | copyright license | Creative Commons Attribution | Q6905323 |
P6216 | copyright status | copyrighted | Q50423863 |
P433 | issue | 7 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | sarcoma | Q223911 |
microRNA | Q310899 | ||
tumor biomarker | Q66205818 | ||
P5008 | on focus list of Wikimedia project | ScienceSource | Q55439927 |
P304 | page(s) | 16593-621 | |
P577 | publication date | 2015-07-22 | |
P1433 | published in | International Journal of Molecular Sciences | Q3153277 |
P1476 | title | What Do We Know about the Role of miRNAs in Pediatric Sarcoma? | |
P478 | volume | 16 |
Search more.